Global Sphingolipid Market for Spectacular Growth, Projected to Reach US$ 991.8 Million by 2032 at a 5.1% CAGR

Sphingolipids Market
Sphingolipids Market

The global sphingolipid market is on track for remarkable growth, poised to exceed a valuation of US$ 564.0 million in 2021 and projected to achieve a Compound Annual Growth Rate (CAGR) of 5.1% by the end of 2032, reaching an estimated value of around US$ 991.8 million.

The synthesis and operation of cell membranes depend on sphingolipids, and lipid-based drug delivery techniques profit substantially from their unique properties. Across a variety of therapeutic domains, sphingolipids offer flexible approaches to improve drug efficacy and bioavailability, from enhancing drug solubility and stability to facilitating targeted administration and controlled release.

Sphingolipids are a diverse family of lipids that are becoming more and more common in pharmaceutical formulations due to their unique properties and potential for therapeutic applications. They are crucial for the structure and signaling of cells. Sphingolipids are predicted to see growth in the market due to the growing demand for both natural and synthetic sphingolipids and monomers in the manufacturing of various pharmaceutical products.

Inform Decisions With a Report Sample:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15713

This factor might significantly improve the adoption and consumption of pharmaceutical sphingolipids. The rising product launches and approvals are expected to contribute to the market growth over the forecast period too.

Key Takeaways from Market Study:

  • Sphingomyelin is the leading segment as a product and holds approximately 0% market share in 2021, due to its anti-cancer, bacteriostatic, and cholesterol-lowering characteristics.
  • Synthetic sphingolipids are the leading segment by source, and held about 4% market share in 2021, owing to their potential as therapeutic prospects for treating a range of medical problems.
  • Conventional lipid-based drug delivery systems (LBDDS) is the leading segment in terms of application holding about 9% of the market share, as compared to traditional tablets or powder-filled capsules, as they can improve bioavailability and reduce dissolving rate-limited absorption because of their pharmacological composition in a solubilized condition.
  • Semi-solid form of sphingolipids is the leading form as of 2021, withholding about 3% of the global market share, owing to the property of reduced adverse side effects when a high drug load is applied to the area where the medication is actually required.
  • Pharmaceutical companies are the leading end users of the global market as of 2021, withholding about 5% of the market share, because of increased outsourcing, innovative modalities, and creative patient outreach tactics.
  • By region, North America is leading in the global sphingolipids market and is expected to continue to do so with a projected CAGR of 4% during the forecasted years.

“Rising initiatives to promote health benefits of sphingolipids products, as well as the increasing ongoing research and development in modifying novel sphingolipids formulations is set to propel the market of sphingolipids across the globe,” says an analyst of Future Market Insights.

Market Competition

Companies are actively working to increase their market share in this industry by forming strategic agreements to diversify their respective service offerings and sphingolipid production capacities.

  • In January 2022, Pfizer and Acuitas Therapeutics reached an agreement on Lipid Nanoparticle Delivery System for mRNA vaccines and therapeutics.
  • June 2022: To support customers’ scientific research, CD Bioparticles, enlarged its lipid system portfolio and introduced a number of Sphingolipids products. With the addition of Phosphosphingolipids, Ceramides, Sphingolipid Metabolism, Sphingosines, Glycosphingolipids, Phytosphingosine, and Sphingomyelin, researchers now have more options to choose from and employ in lipid system applications.

Key Companies Profiled

  • Merck KGaA
  • CordenPharma International
  • Lipoid GmbH
  • LARODAN AB
  • Croda International Plc.
  • Biosynth, Santa Cruz Biotechnology, Inc.
  • Creative Enzymes
  • CD Bioparticles
  • Cayman Chemical Company
  • Biosolve BV

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-15713

Key Segments Covered In Sphingolipids Industry Research

By Product:

  • Ceramide
  • Sphingomyelin
  • Glucosylceramide (GlcCer)
  • Lactosylceramide (LacCer)
  • Ganglioside GM3
  • Other

By Source:

  • Synthetic
  • Semi-synthetic
  • Natural

By Application:

  • Conventional Lipid-based Drug Delivery Systems (LBDDS)
  • Self-Emulsifying Drug Delivery Systems (SEDDS)
  • Self-Microemulsifying Drug Delivery Systems (SMEDDS)
  • Liposomes
  • Solid Lipid Nanoparticles
  • Nanostructured Lipid Carriers
  • Others

By Form:

  • Liquid
  • Semi-solid
  • Solid

By End User:

  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Academics and Research Institutes
  • Others

Get Full Market Analysis Now: Purchase The Report:
https://www.futuremarketinsights.com/checkout/15713

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *